Ha Tay Pharmaceutical JSC Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Jan '21 Jan 1, 2021
Cash & Equivalents	47,198	90,270	301,790	93,132	59,669	60,494
Short-Term Investments	160,000	90,000	80,000	53,000	362,814	16,778
Cash & Short-Term Investments	207,198	180,270	381,790	146,132	422,483	77,273
Cash Growth	-	-52.78%	161.26%	-65.41%	446.74%	41.16%
Accounts Receivable	141,226	125,685	89,463	109,915	121,112	249,858
Other Receivables	8,358	7,927	8,412	8,964	6,859	-12,630
Receivables	149,584	133,612	97,875	118,879	127,972	237,228
Inventory	584,348	527,935	378,908	460,629	339,706	373,510
Other Current Assets	34,799	83,045	150,099	285,297	117,125	45,379
Total Current Assets	975,929	924,861	1,008,673	1,010,937	1,007,287	733,390
Property, Plant & Equipment	997,810	976,101	791,736	442,074	212,752	166,103
Long-Term Investments	18,997	19,336	33,969	11,144	9,486	8,002
Other Intangible Assets	1,377	1,377	1,377	1,593	1,810	2,027
Other Long-Term Assets	3,837	4,631	2,510	3,754	6,256	10,525
Total Assets	1,997,949	1,926,305	1,838,264	1,469,502	1,237,591	920,046
Accounts Payable	320,488	235,207	146,324	196,455	114,143	260,713
Accrued Expenses	28,969	20,668	12,204	16,251	15,269	13,582
Short-Term Debt	282,219	373,274	333,483	234,630	289,429	204,182
Current Income Taxes Payable	2,785	6,057	4,958	8,758	6,288	4,598
Current Unearned Revenue	1,291	909.3	1,008	785.26	551.02	553.13
Other Current Liabilities	160,488	131,637	98,012	106,263	53,399	81,832
Total Current Liabilities	796,239	767,752	595,988	563,143	479,079	565,460
Long-Term Debt	96,913	96,913	170,218	102,213	-	-
Other Long-Term Liabilities	3,793	4,880	4,908	5,306	5,167	4,973
Total Liabilities	896,945	869,545	771,114	670,662	484,245	570,433
Common Stock	823,418	823,418	823,418	264,088	264,088	211,274
Additional Paid-In Capital	97,320	97,320	97,320	315,934	315,934	1,000
Retained Earnings	137,243	90,280	99,006	81,831	79,048	82,134
Treasury Stock	-8,084	-8,084	-8,084	-8,084	-8,084	-8,084
Comprehensive Income & Other	26,612	26,612	26,612	119,572	78,779	39,903
Total Common Equity	1,076,509	1,029,546	1,038,273	773,341	729,766	326,227
Minority Interest	24,495	27,214	28,877	25,499	23,580	23,386
Shareholders' Equity	1,101,004	1,056,760	1,067,150	798,841	753,345	349,613
Total Liabilities & Equity	1,997,949	1,926,305	1,838,264	1,469,502	1,237,591	920,046
Total Debt	379,132	470,187	503,700	336,844	289,429	204,182
Net Cash (Debt)	-171,934	-289,917	-121,910	-190,711	133,054	-126,910
Net Cash Per Share	-1898.26	-3200.88	-2191.63	-	1648.53	-1560.34
Filing Date Shares Outstanding	90.57	90.57	55.63	-	81.33	65.07
Total Common Shares Outstanding	90.57	90.57	55.63	-	81.33	65.07
Working Capital	179,690	157,109	412,684	447,795	528,208	167,930
Book Value Per Share	11885.37	11366.87	18665.49	-	8972.40	5013.66
Tangible Book Value	1,075,133	1,028,170	1,036,896	771,748	727,956	324,201
Tangible Book Value Per Share	11870.18	11351.67	18640.75	-	8950.14	4982.52
Buildings	168,480	165,434	150,724	-	148,602	131,670
Machinery	277,128	272,572	234,134	-	200,702	163,679
Construction In Progress	819,269	790,110	638,852	301,451	64,931	63,328

Source: S&P Global Market Intelligence. Standard template. Financial Sources.